SOPHiA GENETICS (SOPH) Closes $57 Million Public Share Offering

SOPHiA GENETICS (SOPH) announced the closing of its public offering of 10,000,000 common shares on June 21, 2026. The offering generated gross proceeds of approximately $57 million for the company. Shares were priced at $5.70 each. The underwriters also exercised their option to purchase an additional 1,500,000 common shares, contributing to the total proceeds. SOPHiA GENETICS intends to use the net proceeds for general corporate purposes, including working capital, operating expenses, and capital expenditures.